Drugs used to treat schizophrenia are also effective in bipolar disorder. With advances in understanding of psychiatric illnesses, it may be becoming clearer why this is so.
To reach the large number of individuals suffering from depression and anxiety, health care models are being implemented where psychiatrists advise primary care teams.
A recent study investigated the efficacy of deep brain stimulation for severe, treatment-refractory OCD. Over half of the participants in this study showed significant improvement.
There is a striking relationship between a history of psychiatric symptoms and the rate of aging. This relationship is clearly evident by age 45.
Although traumatic brain injury (TBI) involves brain-related symptoms, other organs including the immune system, GI system, lungs, and heart also may become compromised.
A recent paper reported that 1.7% of persons with schizophrenia spectrum disorders died by suicide. About half did so within five years of first diagnosis.
Although psychotic symptoms are often the most dramatic and visible features of schizophrenia, other symptoms are likely responsible for poor long-term outcomes.
Neurosurgical ablation of a specific brain area led to marked improvement in two patients suffering from both treatment-refractory epilepsy and treatment-resistant PTSD.
Two reports indicate that a single intravenous infusion of ketamine can help reduce alcohol consumption in people with problematic drinking behaviors.
Mental health consequences of the pandemic have been dramatic. Young adults are especially susceptible to anxiety and depressive symptoms as well as thoughts of suicide.